Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
24.82
-0.25 (-1.00%)
At close: Sep 8, 2026, 4:00 PM EDT
24.57
-0.25 (-1.01%)
After-hours: Sep 8, 2026, 7:30 PM EDT

Caris Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
105.14-68.09-281.89-341.42-320.83
Depreciation & Amortization
20.7622.6248.914948.25
Other Amortization
5.9912.777.055.382.65
Stock-Based Compensation
65.1170.0118.6415.2422.9
Other Operating Activities
34.6578.98-8.852.82-16.43
Change in Accounts Receivable
-71.58-29.79-33.82-15.08-11.91
Change in Inventory
-79.77-20.755.46-4.44-11.1
Change in Accounts Payable
52.5911.04-0.237.178.91
Change in Other Net Operating Assets
35.666.38-0.485.22-8.16
Operating Cash Flow
168.5683.16-245.2-276.1-285.71
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-44.6-16.26-8.44-22.32-42.26
Investment in Securities
-100.12-61.38237.09-240.73
Investing Cash Flow
-144.72-16.2652.93214.77-282.99

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
-27.87199.98191.31-
Long-Term Debt Repaid
--0.11-0.16-180.74-0.96
Net Debt Issued (Repaid)
-12.9527.76199.8210.57-0.96
Issuance of Common Stock
9.61536.11.531.8711.41
Repurchase of Common Stock
-43.67-18.66---
Other Financing Activities
-6.77-1.44-1.06-2.3-
Financing Cash Flow
-53.78664.99200.2910.1310.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-00.13-00.060
Net Cash Flow
-29.94732.018.02-51.13-558.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
123.9666.9-253.64-298.42-327.96
Free Cash Flow Growth
-----
Free Cash Flow Margin
12.53%8.24%-61.52%-97.48%-126.88%
Free Cash Flow Per Share
0.440.40-7.15-8.54-9.83
Levered Free Cash Flow
63.2653.5-143.65-178.04-
Unlevered Free Cash Flow
86.5876.27-119.44-163.66-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
43.5243.5249.0215.7824.24
Change in Working Capital
-63.09-33.13-29.07-7.13-22.26
SEC Filings: 10-K · 10-Q